IL-1beta-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells.
about
Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantationThe detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases.Toll-like receptor 2 and facial motoneuron survival after facial nerve axotomy.IL-33 promotes DC development in BM culture by triggering GM-CSF productionImmunoregulatory functions of mTOR inhibition.mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS.IL-1β promotes TGF-β1 and IL-2 dependent Foxp3 expression in regulatory T cells.Modulation of adaptive immunity with Toll-like receptorsIL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells.Targeting ST2L potentiates CpG-mediated therapeutic effects in a chronic fungal asthma model.Designing the optimal vaccine: the importance of cytokines and dendritic cells.IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.mTORC2 Deficiency in Myeloid Dendritic Cells Enhances Their Allogeneic Th1 and Th17 Stimulatory Ability after TLR4 Ligation In Vitro and In Vivo.A late IL-33 response after exposure to Schistosoma haematobium antigen is associated with an up-regulation of IL-13 in human eosinophils.Murine dendritic cell rapamycin-resistant and rictor-independent mTOR controls IL-10, B7-H1, and regulatory T-cell inductionGM-CSF-induced CD11c+CD8a--dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditisMicrofilariae of Brugia malayi Inhibit the mTOR Pathway and Induce Autophagy in Human Dendritic CellsCommon genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.IL-33-activated dendritic cells induce an atypical TH2-type response.Tolerogenic dendritic cell-regulatory T-cell interaction and the promotion of transplant tolerance.mTOR: taking cues from the immune microenvironment.The multifunctional role of mTOR in innate immunity: implications for transplant immunity.IL-12hi rapamycin-conditioned dendritic cells mediate IFN-γ-dependent apoptosis of alloreactive CD4+ T cells in vitro and reduce lethal graft-versus-host disease.The role IL-1 in tumor-mediated angiogenesis.Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation.ST2 as a cardiovascular risk biomarker: from the bench to the bedside.Interleukin-33: a mediator of inflammation targeting hematopoietic stem and progenitor cells and their progenies.New dog and new tricks: evolving roles for IL-33 in type 2 immunity.Long non-coding RNA BCAR4 promotes chondrosarcoma cell proliferation and migration through activation of mTOR signaling pathway.Alarmins and Their Receptors as Modulators and Indicators of Alloimmune Responses.Interleukin-33 in health and disease.IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cellsInhibition of mechanistic target of rapamycin promotes dendritic cell activation and enhances therapeutic autologous vaccination in mice.IL-33 induces Th17-mediated airway inflammation via mast cells in ovalbumin-challenged mice.Additive effects of rapamycin and aspirin on dendritic cell allostimulatory capacity.The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine
P2860
Q21284774-4375E330-98C5-4684-A43B-F0CA6D15FB6CQ30497355-4F38F769-842C-4015-B33F-DD80247D97A6Q33593742-FA25B6BC-5279-427F-9EFA-95B84B4DF3D6Q33673185-DD95D738-8606-4CC6-A9D8-EE157B2D485AQ33719228-AA9B7EF1-569F-43E0-BB45-4A7BA70BD245Q33761278-094B23F6-2FB3-427E-AB0F-5C2FA0014AC9Q33931904-92268088-E5B4-465F-A556-D56017B769DBQ33968156-ADE82615-1FF0-4C9F-8594-639684607EA4Q34016666-A0E840B6-FB38-4E54-8BF8-BA04A67092B1Q34289318-B9450378-437B-4440-8DF0-058B3C7D747EQ35070119-4DF20C72-270F-4168-B8D0-CBBD1614CA1DQ35146556-122C9765-B0B4-49A3-AB3B-255C2CD7B4FCQ35402371-78E13999-068A-4FFF-B88B-D0EA2922A1EDQ35562874-89B2049D-2B6F-4881-ABA3-49929A8234B6Q35724182-0FF274B1-DA36-4135-A2E6-EA3A9C4A9C10Q36814620-9AFC2956-DF8B-494B-8AD8-914189230D4BQ37104636-90A3FD65-0068-4C4E-BB8A-CFCE771C1DB4Q37199900-44D1E5C8-13FC-43A7-BD9A-40493A3ACC0CQ37200836-37111109-2271-4491-97FA-0F1339285C98Q37265087-51999251-09E0-42BC-8B5E-8981C7BBC3D6Q37353045-AC42F9F9-BA14-43DB-98FB-9E23862623B6Q37552045-45324E11-2B02-4E39-87B2-21C7BAE4CBC8Q37605193-C5BEB11E-E1C9-409C-BF7F-F31C5C92C1E4Q37661441-DF98C902-AA47-4DE5-9AE0-46926B6F4EB5Q37683553-0CB36D6D-B13D-4E8E-A8DE-FE2833EA4699Q37716661-A625B38C-24E2-4E9C-BA81-5AEEF0630694Q38096251-B801A69D-5DE5-46EF-AD94-BF0732C75339Q38105069-4D16F388-00F1-4504-8D89-1DB80C9893FBQ38388349-D36D73FF-AAF6-4AC7-980C-E97F40EB7C10Q38708065-828A19C1-1CFB-411A-81C2-0CA9784702DDQ38845953-26AACDE4-0C07-4BAF-B24B-10AC99157A5AQ38957840-CDC0175B-3261-44F2-943F-684F868D2FC3Q41965694-0A0CAEFA-0382-4647-BEDD-B48BDCB0D001Q41976514-DF552107-15D9-4511-A6B9-9BB48B068A5CQ53093209-A90A8A85-142C-4520-B7A2-EA9DF76315F1Q53311604-5A0A93CD-8039-4791-89BE-718532A19609Q58707724-CAB4F98E-25D4-413E-8354-30C2607D1D15
P2860
IL-1beta-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
IL-1beta-driven ST2L expressio ...... n-conditioned dendritic cells.
@ast
IL-1beta-driven ST2L expressio ...... n-conditioned dendritic cells.
@en
IL-1beta-driven ST2L expressio ...... n-conditioned dendritic cells.
@nl
type
label
IL-1beta-driven ST2L expressio ...... n-conditioned dendritic cells.
@ast
IL-1beta-driven ST2L expressio ...... n-conditioned dendritic cells.
@en
IL-1beta-driven ST2L expressio ...... n-conditioned dendritic cells.
@nl
prefLabel
IL-1beta-driven ST2L expressio ...... n-conditioned dendritic cells.
@ast
IL-1beta-driven ST2L expressio ...... n-conditioned dendritic cells.
@en
IL-1beta-driven ST2L expressio ...... n-conditioned dendritic cells.
@nl
P2093
P2860
P1476
IL-1beta-driven ST2L expressio ...... n-conditioned dendritic cells.
@en
P2093
Alan F Zahorchak
Allan Tsung
Angus W Thomson
Atsunori Nakao
David A Geller
Gerard J Nau
Heth R Turnquist
Tina L Sumpter
P2860
P356
10.4049/JIMMUNOL.181.1.62
P407
P50
P577
2008-07-01T00:00:00Z